Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs72754922 | chr5:42547714 | G/A | 9.44E-5 | 132 | 37.95 | 52.43 | 20.23 | KM Plot |
| TGCT | rs72780141 | chr16:27808472 | T/G | 1.04E-5 | 133 | 46.53 | 33.55 | 17.27 | KM Plot |
| TGCT | rs72780144 | chr16:27809318 | A/G | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs72780146 | chr16:27809888 | G/A | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs72780157 | chr16:27815518 | G/A | 1.28E-5 | 130 | 45.7 | 38.2 | 17.27 | KM Plot |
| TGCT | rs72973380 | chr3:125631030 | G/C | 2.41E-5 | 131 | 51.67 | 35.37 | 52.43 | KM Plot |
| TGCT | rs7297785 | chr12:107041456 | G/T | 3.36E-8 | 134 | 27.93 | 38.2 | 48.87 | KM Plot |
| TGCT | rs73017232 | chr3:10059664 | T/C | 2.38E-5 | 129 | 41.27 | 60.73 | 22.98 | KM Plot |
| TGCT | rs7309351 | chr12:107077432 | C/T | 5.07E-5 | 134 | 28.67 | 45.1 | 46.77 | KM Plot |
| TGCT | rs73128366 | chr4:37241908 | T/C | 0 | 133 | 45.83 | 31.75 | 0.5 | KM Plot |
| TGCT | rs73128373 | chr4:37244986 | G/C | 0 | 133 | 45.83 | 31.75 | 0.5 | KM Plot |
| TGCT | rs73128374 | chr4:37245463 | C/T | 0 | 133 | 45.83 | 31.75 | 0.5 | KM Plot |
| TGCT | rs73138870 | chr20:58151064 | T/G | 2.81E-13 | 131 | 41.33 | 59.3 | 17.1 | KM Plot |
| TGCT | rs73138871 | chr20:58151894 | C/T | 3.62E-13 | 130 | 42.18 | 76.63 | 17.1 | KM Plot |
| TGCT | rs73138883 | chr20:58155307 | G/A | 3.92E-13 | 129 | 43.68 | 42.03 | 17.1 | KM Plot |